Blogg

  • Reset
6.30.21 | Policy
Integrating Women into Health Care Research, Quality Improvement, and Value Assessment

Across research and health policy, the unique needs of women as patients, caregivers, and primary health care decision-makers for their families are receiving more attention.

6.24.21 | Coronavirus
Converging Health Crises: The Impact of COVID-19 and the Opioid Epidemic on Pregnant Women

The national opioid epidemic was already raging before COVID-19 hit the United States. During the pandemic, the situation severely worsened, including for those who are pregnant.   

6.23.21 | Genetic Screening
Expanded Carrier Screening: Eliminating Barriers to Access and Reducing Disparities

SWHR convened an interdisciplinary working group for a closed roundtable meeting to discuss how to eliminate barriers to access and reduce health disparities related to genetic screening, with a focus on noninvasive prenatal screening (NIPS) and expanded carrier screening (ECS).

6.22.21 | Policy
SWHR Urges Congressional Leaders to Support Public Health Infrastructure Saves Lives Act

6.21.21 | Genetic Screening
Noninvasive Prenatal Screening: Eliminating Barriers to Access and Reducing Disparities

SWHR convened an interdisciplinary working group for a closed roundtable meeting to discuss how to eliminate barriers to access and reduce health disparities related to genetic screening, with a focus on noninvasive prenatal screening (NIPS) and expanded carrier screening (ECS).

6.15.21 | Uterine Fibroids
Congressional Briefing: Supporting Women with Fibroids Through Policy Action

SWHR hosted a virtual congressional briefing to raise awareness of policy needs to improve care for individuals with uterine fibroids, a condition that is underfunded and often overlooked in research. 

6.3.21 | Autoimmune
Identifying Knowledge Gaps and Unmet Needs in Autoimmune Skin Conditions

SWHR convened a working group of basic and clinical researchers, health care providers, patients/patient advocates, and policy leaders for a closed, two-day roundtable meeting to discuss the health, social, and economic impacts of alopecia, atopic dermatitis, and psoriatic arthritis on women.

6.2.21 | Policy
SWHR Letter to ICER on Draft Evidence Report for Alzheimer’s Drug Aducanumab

5.21.21 | Policy
SWHR Urges Secretary Becerra to Prioritize Offices of Women’s Health

5.21.21 | Policy
SWHR Asks Congress to Prioritize Osteoporosis in FY22 Appropriations Bill